Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1731
| Despition | DNAJC19 Human Recombinant |
| SIZE | 2 µg |
| Purity | > 90.0% (SDS-PAGE) |
| Form | Sterile Filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1604 | Human GSK3B Protein (AC1604) | 2 µg | inquiry |
| ACPP-1557 | Human TARDBP Protein (AC1557) | 2 µg | inquiry |
| ACPP-1834 | Human BAALC Protein (AC1834) | 2 µg | inquiry |
| ACPP-1465 | Human CHRNA3 Protein (AC1465) | 5 µg | inquiry |
| ACPP-1207 | Dopamine Receptor D1 Blocking Peptide (AC1207) | 250 µg | inquiry |
| ACPP-1407 | Human HOMER3 Protein (AC1407) | 5 µg | inquiry |
| ACPP-1469 | Human S100A8 Protein (AC1469) | 5 µg | inquiry |
| ACPP-1686 | Human Acrp30 Protein, HEK (AC1686) | 2 µg | inquiry |
| ACPP-1056 | Recombinant Human CX3CR1 Protein (Fc Tag) (AC1056) | 50 µg | inquiry |
| ACPP-1260 | iNOS Blocking Peptide (AC1260) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.